Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival

Fig. 6

Kaplan–Meier survival curves of overall survival for SP expression in patients with breast cancer (log-rank test). a). Overall survival based on SP expression in pooled samples. b). Overall survival based on SP expression in HER2-enriched cases. c). Overall survival based on SP expression in luminal A cases. d). Overall survival based on SP expression in triple positive cases. e). Overall survival based on SP expression in triple negative cases. f). Overall survival based on SP expression in HR-ve cases. g). Overall survival based on SP expression in HR + ve cases. h). Overall survival based on SP expression HR-ve cases with low NK1R expression level. i). Overall survival based on SP expression in HR-ve cases with low Ki-67 index

Significant differences were calculated using the log-rank test. p < 0.05 is statistically significant

Abbreviations: SP: substance P; HER2: human epidermal growth factor receptor type 2; HR-ve: hormone receptor negative; HR + ve: hormone receptor positive; NK1R: neurokinin 1 receptor.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us